Nigeria’s combat in opposition to HIV and AIDS could also be approaching a turning level with the introduction of Lenacapavir, a long-acting injectable drug that specialists say might vastly cut back new infections.
Administered twice yearly to HIV-negative people at substantial threat, the innovation is being positioned as a crucial device in accelerating Nigeria’s aim of ending HIV/AIDS as a public well being threat by 2030.
Globally, HIV stays a serious public well being problem, with about 1.3 million new infections recorded yearly, at the same time as remedy and prevention efforts have improved outcomes.
In Nigeria, the burden stays appreciable, with roughly 48,000 new infections annually.
These figures spotlight persistent gaps in prevention amongst key and susceptible populations and underscore the urgency for more practical and accessible choices.
Progresses to date
Nigeria has made notable progress in recent times. The minister of state for well being and social welfare, Dr Iziaq Salako mentioned 93 per cent of individuals dwelling with HIV now know their standing, 99 per cent of these identified are on remedy whereas 95 per cent of these on remedy have achieved viral suppression.
He added that Prevention of Mom-to-Baby Transmission protection had risen from 33 per cent in 2023 to almost 70 per cent in 2025. But, specialists say the speed of latest infections stays too excessive, making prevention the subsequent crucial frontier in Nigeria’s HIV response.
Lenacapavir, a long-acting antiretroviral drug used for pre-exposure prophylaxis (PrEP) and really useful by the World Well being Organisation in July 2025, now represents contemporary hope on this effort.
Not like day by day oral PrEP, the drug is run as soon as each six months, providing a extra handy and adherence-friendly possibility.
Lenacapavir to the rescue
Scientific trials present that Lenacapavir can forestall almost all circumstances of HIV amongst individuals in danger, making it probably the most efficient prevention instruments at the moment out there.
The director-general of the World Well being Organisation, Dr Tedros Ghebreyesus, described the drug as essentially the most important growth in HIV prevention in many years.
He famous that HIV, as soon as thought-about a dying sentence, has grow to be a manageable situation with AIDS-related deaths declining by about 70 per cent globally over the previous 20 years, whereas stressing that prevention stays important to ending the epidemic.
Nigeria’s adoption of Lenacapavir as certainly one of 9 early adopter nations marks a serious milestone in its HIV response. An preliminary 52,000 doses have been offered by the International Fund to catalyse the drug’s introduction.
The senior fund portfolio supervisor on the International Fund, Mr Jean-Thomas Nouboussi, disclosed that Nigeria would obtain a complete of 179,700 doses by 2028. He described Lenacapavir as a breakthrough in HIV prevention, addressing adherence challenges related to day by day oral PrEP.
He added that the International Fund goals to succeed in two million individuals globally with the drug by 2028, noting that its assist to Nigeria is catalytic.
“We anticipate the federal government would step in and speed up deployment throughout the nation,” he mentioned.
Implementation has commenced in eight pilot states of Anambra, Ebonyi, Gombe, Kwara, Akwa Ibom, Cross River, Benue and the FCT; with a phased nationwide scale-up deliberate thereafter.
Innovation good for the inhabitants
Dr Temitope Ilori, director-general of the Nationwide Company for the Management of AIDS (NACA), mentioned the innovation would improve adherence and compliance amongst high-risk populations.
She famous that the drug was not really useful for pregnant ladies and ought to be used inside a broader mixture prevention method.
“It is a very revolutionary prevention technique that may improve adherence and compliance. It doesn’t forestall sexually transmitted infections or undesirable pregnancies,” she mentioned.
In line with Ilori, the introduction displays sturdy nationwide coordination and dedication to epidemic management and increasing prevention choices is crucial to closing gaps and reaching populations most in danger.
The Joint United Nations Programme on HIV/AIDS (UNAIDS) additionally underscored the significance of sustaining prevention good points by way of revolutionary instruments and continued collaboration.
The nation director, Ms Tina Bonto, mentioned funding constraints and prevention gaps nonetheless pose dangers to attaining epidemic management.
She famous that Nigeria’s early adoption displays its management in HIV prevention, having pioneered oral PrEP in 2016 and repeatedly expanded prevention choices by way of sturdy partnerships.
“There are nonetheless about 48,000 new infections yearly; so extra effort is required to shut prevention gaps,” she mentioned, expressing optimism that Lenacapavir would speed up progress towards epidemic management.
Why oral PrEp was not so efficient
Public well being specialists say one of many largest challenges in HIV prevention has been poor adherence to day by day medicine. For a lot of at-risk people; together with intercourse employees, males who’ve intercourse with males, individuals who inject medicine and adolescent women, day by day drugs are troublesome to keep up constantly.
Stigma, discrimination, and social limitations typically discourage sustained use of oral PrEP.
Lenacapavir addresses this hole by requiring solely two injections a 12 months, decreasing the burden of day by day compliance.
Its discreet nature additionally makes it extra acceptable for people who could keep away from HIV companies attributable to stigma.
Josephine Aseme, chairperson of the Nigeria Key Inhabitants Well being and Rights Community, described the drug as a serious breakthrough for susceptible communities.
“I used to be as soon as an oral PrEP person, however I needed to cease. I’ve volunteered to be among the many first to obtain Lenacapavir,” she mentioned, including that the injectable possibility would enhance adherence and pledged neighborhood assist to drive consciousness and uptake.
Civil society {groups} have known as for broader availability past narrowly outlined populations to make sure nobody in danger is left behind.
Dr Abdulkadir Ibrahim of the Community of Individuals Dwelling with HIV/AIDS in Nigeria urged the federal government to prioritise accessibility and home funding.
“We should always make this out there and accessible in order that we will forestall new infections throughout communities,” he mentioned.
Dr Adebobola Bashorun, Nationwide Coordinator of the Nationwide AIDS, Viral Hepatitis and Sexually Transmitted Infections Management Programme mentioned the rollout was guided by nationwide knowledge and stakeholder collaboration.
He famous that no main opposed occasions had been recorded, with solely gentle injection-site ache noticed as a standard aspect impact.
He added that the programme prioritised fairness and entry, with the federal government initially main implementation earlier than increasing engagement with the personal sector.
Govt’s dedication to ending HIV
The coordinating minister of well being and social welfare, Prof Muhammad Ali Pate mentioned the federal government stays dedicated to ending HIV by way of a complete, multi-sectoral method.
“This includes leveraging innovation, enhancing effectivity, and strengthening home financing to maintain progress in HIV, tuberculosis, and malaria management”.
He revealed that the federal authorities, with contributions from states and native authorities, has dedicated 346 million {dollars} in co-financing for HIV, TB, malaria, and different strategic well being investments in 2026.
“By 2030, Nigeria ought to be capable of put its personal home assets towards precedence ailments as an alternative of counting on exterior grants,” he mentioned.
{Economic} implications
Past well being outcomes, the introduction of Lenacapavir carries {economic} implications.
By stopping new infections, Nigeria might cut back long-term remedy prices and ease strain on the well being system.
The everlasting secretary, Federal Ministry of Well being and Social Welfare, Ms Daju Kachollom mentioned the innovation aligns with nationwide efforts to broaden prevention choices and enhance entry.
She famous {that a} Nationwide PrEP Implementation Plan (2025–2028) had been developed to information the rollout, overlaying service supply, provide chains, demand creation, and sustainability.
If correctly carried out, analysts say Lenacapavir might considerably cut back Nigeria’s roughly 48,000 annual new infections and speed up progress towards epidemic management.
On the world degree, wider adoption of such extremely efficient prevention instruments might additionally assist drive down the 1.3 million new infections recorded worldwide annually.
Current challenges however, stakeholders say Lenacapavir gives renewed hope within the combat in opposition to HIV/AIDS.
With sustained political will, neighborhood engagement and ample funding, Nigeria could also be nearer than ever to ending HIV as a public well being threat.
For tens of millions in danger, the twice-yearly injection represents not only a medical breakthrough however a pathway to a future free of latest HIV infections.